Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TRANSITION THERAPEUTICS INC. T.TTH

"Transition Therapeutics Inc is a product-focused biopharmaceutical company. The Company is engaged in developing therapeutics for disease indications with markets. Its technologies are focused on the treatment of Alzheimer's disease and diabetes."


TSX:TTH - Post by User

Post by deninsaskon Dec 13, 2006 10:17pm
288 Views
Post# 11864259

Not much .........

Not much ......... DYK.......Not much to talk about Hepc for awhile until the Trial is completed seeing that we only have the 12 week data and there is a 36 week follow-up. That should bring it to somewhere around mid March to April 13th for the Trial to be completed and Results to be announced. The only news re: Hepc before then would be a partnership. Once again I think many including dyk will be surprised at the PPS leading into INT news, more interest from south of the border would push us back up to 52 week highs. CitiGroup only bought up $4,000,000.00cdn ....Maybe they can find another $1mil or $2mil......look to both Trials being released simultaneously.
Bullboard Posts